Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by mercedesmanon Dec 02, 2021 10:23pm
119 Views
Post# 34193160

RE:RE:RE:RE:MBX Tweets it is working on Omicron

RE:RE:RE:RE:MBX Tweets it is working on Omicron

wizzdumb wrote: Yes, I read the same article. If that's true (no scientific fact yet) then testing will be pointless because everyone will be positive. So not so good news for MBX then. 


testing will not go away, it will ramp up.
to suggest everyone will get omicron is nothing short of irresponsible - especially as the next round of new vaccines hit in March or so.  


Of course, throughout flu season and winter people will want to know...do I have flu? delta? Omicron? ( therapeutics for each version likely will have differences) 

In fact therein also lies a new opportunity for MBX 

multiplex testing..." what exactly do I have Doc?" 

Also there will be increased demand for Antibody testing... did I have it? Which one? Do I have any protection left.? 

there will be a need for new antibodies to be used in research 


This Endemic is every: vaccine producer's, every test provider's, every   Therapeutic drug maker's, every  antibody tester's, every VTM supplier's 
wet dream. 

Just when you think it's over, the process starts all over again. 


The only issue is if the next version kills 5%, and the one after that 10% and the one after that...

... in which case sell some of your MBX shares on the way up, and buy a Metaverse vacation property and a virtual reality headset to enjoy some of your remaining days. 
 

<< Previous
Bullboard Posts
Next >>